ALPS Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,087
| Closed | -$1.12M | – | 1062 |
|
|
2021
Q2 | $1.12M | Sell |
6,087
-139
| -2% | -$25.5K | 0.01% | 392 |
|
|
2021
Q1 | $952K | Sell |
6,226
-1,029
| -14% | -$157K | 0.01% | 402 |
|
|
2020
Q4 | $1.13M | Sell |
7,255
-690
| -9% | -$108K | 0.01% | 376 |
|
|
2020
Q3 | $909K | Buy |
+7,945
| New | +$909K | 0.01% | 363 |
|
|
2018
Q1 | – | Sell |
-3,265
| Closed | -$390K | – | 1021 |
|
|
2017
Q4 | $390K | Hold |
3,265
| – | – | ﹤0.01% | 686 |
|
|
2017
Q3 | $458K | Sell |
3,265
-1,607
| -33% | -$225K | ﹤0.01% | 654 |
|
|
2017
Q2 | $593K | Buy |
4,872
+945
| +24% | +$115K | ﹤0.01% | 365 |
|
|
2017
Q1 | $476K | Buy |
+3,927
| New | +$476K | ﹤0.01% | 546 |
|
|
2015
Q3 | – | Sell |
-2,868
| Closed | -$518K | – | 796 |
|
|
2015
Q2 | $518K | Buy |
2,868
+44
| +2% | +$7.95K | ﹤0.01% | 467 |
|
|
2015
Q1 | $489K | Sell |
2,824
-444
| -14% | -$76.9K | ﹤0.01% | 600 |
|
|
2014
Q4 | $605K | Sell |
3,268
-432
| -12% | -$80K | ﹤0.01% | 260 |
|
|
2014
Q3 | $614K | Buy |
+3,700
| New | +$614K | ﹤0.01% | 237 |
|
|
2014
Q1 | – | Sell |
-4,176
| Closed | -$663K | – | 695 |
|
|
2013
Q4 | $663K | Buy |
4,176
+2,032
| +95% | +$323K | 0.01% | 169 |
|
|
2013
Q3 | $249K | Buy |
+2,144
| New | +$249K | ﹤0.01% | 457 |
|